Şengün İnan Figen, Üstün Besti
Author Affiliations: Department of Psychiatric Nursing, Faculty of Nursing, Dokuz Eylül University (Dr Şengün İnan), Izmir; and Nursing Department, Faculty of Health, Üsküdar University (Prof Üstün), Istanbul, Turkey.
Cancer Nurs. 2018 May/Jun;41(3):238-247. doi: 10.1097/NCC.0000000000000483.
It is important to manage psychological distress and improve the quality of life (QOL) in patients after breast cancer treatment.
The aim of this study was to evaluate the effects of a home-based, psychoeducational program on distress, anxiety, depression, and QOL in breast cancer survivors.
The study was a single-group pretest and posttest quasi-experimental design. The data were collected using the Distress Thermometer, the Hospital Anxiety and Depression Scale, and the Turkish version of the World Health Organization Quality of Life Instrument, short form. The home-based, individual, face-to-face psychoeducational program was structured according to breast cancer survivors' needs and the Neuman Systems Model.
A total of 32 Turkish breast cancer survivors participated in this study. There were statistically significant differences in the mean scores for distress, anxiety, and depression in the breast cancer survivors over 4 measurements. The mean scores for all subscales of the QOL at 6 months postintervention were significantly higher than the mean scores at baseline.
The results indicated that the psychoeducational program may be effective in reducing distress, anxiety, and depression and in improving the QOL in breast cancer survivors.
Psychoeducational programs may be effective and should be considered as part of the survivorship care for breast cancer survivors.
在乳腺癌治疗后的患者中，管理心理困扰并提高生活质量（QOL）很重要。
本研究的目的是评估一项基于家庭的心理教育项目对乳腺癌幸存者的困扰、焦虑、抑郁和生活质量的影响。
该研究采用单组前测和后测的准实验设计。使用困扰温度计、医院焦虑抑郁量表以及土耳其语版世界卫生组织生活质量量表简表收集数据。基于家庭的、个体面对面的心理教育项目是根据乳腺癌幸存者的需求和纽曼系统模式构建的。
共有32名土耳其乳腺癌幸存者参与了本研究。在4次测量中，乳腺癌幸存者的困扰、焦虑和抑郁平均得分存在统计学显著差异。干预后6个月时，生活质量所有子量表的平均得分显著高于基线时的平均得分。
结果表明，心理教育项目可能在减轻乳腺癌幸存者的困扰、焦虑和抑郁以及改善其生活质量方面有效。
心理教育项目可能有效，应被视为乳腺癌幸存者生存护理的一部分。
